Karin Olson

Gleason Pattern 5 Is the Greatest Risk Factor for Clinical Failure and Death From Prostate Cancer After Dose-Escalated Radiation Therapy and Hormonal Ablation

Aaron Sabolch, Felix Y. Feng, Stephanie Daignault‐Newton et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 72 citations

Medicine, Radiation Oncology, Urology +17

Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy

Jeffrey M. Vainshtein, Eyad Abu‐Isa, Karin Olson et al. · Radiation Oncology · 2012 · 58 citations · Full text

Medicine, Oncology, Urology +17

Age and Comorbid Illness Are Associated With Late Rectal Toxicity Following Dose-Escalated Radiation Therapy for Prostate Cancer

Daniel A. Hamstra, M.H. Stenmark, Tim Ritter et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 52 citations

Medicine, Oncology, Radiation Oncology +17

Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone‐refractory prostate carcinoma

David C. Smith, Christopher H. Chay, Rodney L. Dunn et al. · Cancer · 2003 · 36 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen‐independent prostate carcinoma

Beth A. Hellerstedt, Kenneth J. Pienta, Bruce G. Redman et al. · Cancer · 2003 · 35 citations · Full text

Medicine, Oncology, Pharmacology +13